日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

p53 ensures the normal behavior and modification of G1/S-specific histone H3.1 in the nucleus

p53 确保细胞核中 G1/S 特异性组蛋白 H3.1 的正常行为和修饰

期刊:Life Science Alliance
影响因子:3.3
doi:10.26508/lsa.202402835
Tsukasa Oikawa, Junya Hasegawa, Haruka Handa, Naomi Ohnishi, Yasuhito Onodera, Ari Hashimoto, Junko Sasaki, Takehiko Sasaki, Koji Ueda, Hisataka Sabe
细胞生物学
表观遗传
其它细胞
发表日期：2024
文献求助 收藏

Draft Genome Sequence of Bryobacteraceae Strain F-183

布氏杆菌科菌株 F-183 的基因组草图序列

期刊:Microbiology Resource Announcements
影响因子:0.6
doi:10.1128/mra.00453-21
Yamamoto, Kyosuke; Yoneda, Yasuko; Makino, Ayaka; Tanaka, Yasuhiro; Meng, Xian-Ying; Hashimoto, Junko; Shin-Ya, Kazuo; Satoh, Noriyuki; Fujie, Manabu; Toyama, Tadashi; Mori, Kazuhiro; Ike, Michihiko; Morikawa, Masaaki; Kamagata, Yoichi; Tamaki, Hideyuki
发表日期：2022
文献求助 收藏

Complete Genome Sequence of Luteitalea sp. Strain TBR-22

黄杆菌属 TBR-22 菌株的完整基因组序列

期刊:Microbiology Resource Announcements
影响因子:0.6
doi:10.1128/mra.00455-21
Yamamoto, Kyosuke; Yoneda, Yasuko; Makino, Ayaka; Tanaka, Yasuhiro; Meng, Xian-Ying; Hashimoto, Junko; Shin-Ya, Kazuo; Satoh, Noriyuki; Fujie, Manabu; Toyama, Tadashi; Mori, Kazuhiro; Ike, Michihiko; Morikawa, Masaaki; Kamagata, Yoichi; Tamaki, Hideyuki
发表日期：2022
文献求助 收藏

Effectiveness of monthly intravenous ibandronate injections in a real-world setting: Subgroup analysis of a postmarketing observational study

每月一次静脉注射伊班膦酸钠在真实世界中的疗效：一项上市后观察性研究的亚组分析

期刊:
影响因子:
doi:10.1016/j.afos.2019.02.002
Takeuchi, Yasuhiro; Hashimoto, Junko; Kakihata, Hiroyuki; Nishida, Yousuke; Kumagai, Michiko; Yamagiwa, Chiemi
发表日期：2019
文献求助 收藏

Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis

一项前瞻性、上市后观察性研究评估了每月一次静脉注射伊班膦酸钠治疗日本骨质疏松症患者的安全性和有效性

期刊:
影响因子:
doi:10.1016/j.afos.2018.01.001
Takeuchi, Yasuhiro; Hashimoto, Junko; Nishida, Yosuke; Yamagiwa, Chiemi; Tamura, Takashi; Atsumi, Akihide
代谢
骨质疏松
发表日期：2018
文献求助 收藏

Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host.

利用特定启动子在纯净宿主中鉴定端粒酶抑制剂生物合成基因簇并进行异源表达

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-03308-5
Amagai Keita, Ikeda Haruo, Hashimoto Junko, Kozone Ikuko, Izumikawa Miho, Kudo Fumitaka, Eguchi Tadashi, Nakamura Takemichi, Osada Hiroyuki, Takahashi Shunji, Shin-Ya Kazuo
信号转导
发表日期：2017
文献求助 收藏

Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats

间歇性使用伊班膦酸钠可维持卵巢切除大鼠停用甲状旁腺激素治疗后的骨量、骨结构以及松质骨和皮质骨的生物力学强度。

期刊:Calcified Tissue International
影响因子:3.2
doi:10.1007/s00223-017-0255-6
Takeda, Satoshi; Sakai, Sadaoki; Tanaka, Keisuke; Tomizawa, Haruna; Serizawa, Kenichi; Yogo, Kenji; Urayama, Koji; Hashimoto, Junko; Endo, Koichi; Matsumoto, Yoshihiro
Rat
免疫/内分泌
发表日期：2017
文献求助 收藏

Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites

工程改造的链霉菌（Streptomyces avermitilis）宿主用于异源表达次级代谢产物的生物合成基因簇

期刊:ACS Synthetic Biology
影响因子:3.9
doi:10.1021/sb3001003
Komatsu, Mamoru; Komatsu, Kyoko; Koiwai, Hanae; Yamada, Yuuki; Kozone, Ikuko; Izumikawa, Miho; Hashimoto, Junko; Takagi, Motoki; Omura, Satoshi; Shin-ya, Kazuo; Cane, David E; Ikeda, Haruo
代谢
发表日期：2013
文献求助 收藏

Clinical efficacy on fracture risk and safety of 0.5 mg or 1 mg/month intravenous ibandronate versus 2.5 mg/day oral risedronate in patients with primary osteoporosis

0.5 mg 或 1 mg/月静脉注射伊班膦酸钠与 2.5 mg/天口服利塞膦酸钠治疗原发性骨质疏松症患者，在骨折风险和安全性方面的临床疗效及安全性比较

期刊:Calcified Tissue International
影响因子:3.2
doi:10.1007/s00223-013-9734-6
Nakamura, Toshitaka; Nakano, Tetsuo; Ito, Masako; Hagino, Hiroshi; Hashimoto, Junko; Tobinai, Masato; Mizunuma, Hideki
代谢
骨折
骨质疏松
发表日期：2013
文献求助 收藏